what does glp-1 do in the body for Weight Loss and Diabetes Benefits of Semaglutide GLP-1 Injections

2020;18(Suppl 1):18

In the GLP-1 receptor agonist market, Novo Nordisk A/S leads with its market-dominating semaglutide, positioning itself as the frontrunner in diabetes and obesity treatments

J., Sandoval, D., & DAlessio, D

Their smaller molecular structure also facilitates better tissue penetration and lower production costs, which could enhance accessibility to these novel medications

For example, GLP1RAs-induced weight loss might affect drug distribution

This delay prolongs nutrient absorption and stabilizes post-meal glucose responses, reducing spikes that can contribute to fat accumulation and energy crashes